←Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma
Ranjana Advani
MD
🏢Stanford University🌐USA
Saul Rosenberg Professor of Lymphoma
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ranjana Advani has led numerous pivotal Hodgkin lymphoma trials including combinations of brentuximab vedotin with checkpoint inhibitors and co-led the SWOG S1826 trial of brentuximab versus nivolumab plus AVD. She directs lymphoma research at Stanford.
Share:
🧪Research Fields 研究领域
Hodgkin lymphoma
brentuximab vedotin
nivolumab combinations
SWOG S1826
relapsed Hodgkin
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ranjana Advani 的研究动态
Follow Ranjana Advani's research updates
留下邮箱，当我们发布与 Ranjana Advani（Stanford University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment